Top Antimicrobial Textile Companies

Antimicrobial Textile Market size was valued at USD 12.67 Billion in 2023 and is poised to grow from USD 13.65 Billion in 2024 to USD 22.94 Billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The global antimicrobial textile market is relatively fragmented, with high competition. Few large players, like SANITIZED AG, Sciessent LLC, The Dow Chemical Company, Trevira GmbH, Life Threads LLC, Unitika Trading Co. Ltd., BASF SE, Microban International Ltd., Milliken Chemical, Lonza Group AG, Herculite Products Inc., PurThread Technologies Inc., BioCote Ltd., now control the market in terms of market share. These antimicrobial textile industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Indorama Ventures Fibers Germany ', 'Herculite ', 'UNITIKA LTD ', 'PurThread Technologies, Inc. ', 'LifeThreads ', 'Rajshree Fabrics. ', 'Baltex ', 'Milliken ', 'BioCote Ltd. ', 'Microban International, Ltd. ', 'BASF SE ', 'Lonza Group Ltd. ', 'The Dow Chemical Company ', 'DuPont de Nemours, Inc. ', 'HeiQ Materials AG ', 'Foss Performance Materials ', 'Sciessent LLC ', 'Sanitized AG ', 'PurThread Technologies, Inc. ', 'Sinterama S.p.A.'

Antimicrobial substances are used to either eradicate or stop the spread of microorganisms. Fabrics having antimicrobial chemicals added to the surface or inside the fibers are said to have antimicrobial fibers. Antimicrobial substances are combined with dyes or pigments, added to the fiber during spinning or extrusion, or applied as a finishing step.

The demand for high-performance, microbe-resistant fabrics for a growing variety of application sectors and technological advancements for their manufacture are the two main factors driving the global antimicrobial textile market. The market's expansion is also being fueled by the entry of numerous local companies as well as ongoing research and development activities for the creation of active compounds that do not penetrate the skin and are gentle on the skin.

Owing to limitations in the current medication therapy, treatment, and management of orthopedic, cardiovascular, ophthalmic, neurological, and a number of other chronic conditions, North America dominates the global antimicrobial fabrics market. Additionally, the antimicrobial fabrics market in the region is expected to increase due to ongoing technological advancements, which will eventually result in the production of new and improved products. Due to increased governmental involvement in improving healthcare facilities, Asia-Pacific is expected to have considerable growth in the antimicrobial textiles market. Additionally, the expanding wound care industry is predicted to increase demand for the goods, and the presence of significant yarn and fibre producers in Taiwan is predicted to further fuel the expansion of the antimicrobial textiles market in the region over the next few years.